Atypical pemphigus developed in a patient with urothelial carcinoma treated with nivolumab

J Dermatol. 2019 Mar;46(3):e90-e92. doi: 10.1111/1346-8138.14601. Epub 2018 Aug 31.

Authors

Michiko Ito¹, Toshihiko Hoashi¹, Yuki Endo², Go Kimura², Yukihiro Kondo², Norito Ishii³, Takashi Hashimoto⁴, Yoko Funasaka¹, Hidehisa Saeki¹

Affiliations

¹ Department of Dermatology, Nippon Medical School, Tokyo, Japan.
² Department of Urology, Nippon Medical School, Tokyo, Japan.
³ Department of Dermatology, Kurume University School of Medicine, Kurume, Japan.
⁴ Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan.

PMID: 30168864
DOI: 10.1111/1346-8138.14601

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antineoplastic Agents, Immunological / adverse effects*
Biopsy
Carcinoma, Transitional Cell / therapy*
Chemotherapy, Adjuvant / adverse effects
Chemotherapy, Adjuvant / methods
Humans
Male
Nivolumab / adverse effects*
Pemphigus / chemically induced*
Pemphigus / diagnosis
Pemphigus / immunology
Pemphigus / pathology
Radiotherapy, Adjuvant
Skin / drug effects
Skin / pathology
Ureter / surgery
Ureteral Neoplasms / therapy*

Substances

Antineoplastic Agents, Immunological
Nivolumab